Collin-Jamal Smith
Dermatology · Chapel Hill, NCNPI 1093335820
Payments from drug & device makers
Across 217 payments — averaging $20.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- UCB, Inc.$510
- Sanofi$437
- AbbVie$435
- E.r. Squibb & Sons, L.L.C.$368
- Regeneron Healthcare Solutions, Inc.$363
- Amgen$268
- plus $2K from 17 others
What the payments were for
- Food & beverage$4,341100%
- Education$100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| UCB, Inc. | 19 | $510 |
| Sanofi | 17 | $437 |
| AbbVie | 28 | $435 |
| E.r. Squibb & Sons, L.L.C. | 19 | $368 |
| Regeneron Healthcare Solutions, Inc. | 17 | $363 |
| Amgen | 11 | $268 |
| Sun Pharmaceutical Industries Inc. | 11 | $257 |
| Novartis | 11 | $256 |
| Johnson & Johnson | 14 | $232 |
| Incyte Corporation | 8 | $203 |
| Lilly USA, LLC | 10 | $188 |
| Galderma Laboratories, L.p. | 17 | $174 |
| Pfizer | 8 | $158 |
| Arcutis Biotherapeutics, Inc. | 9 | $151 |
| LEO Pharma Inc. | 6 | $116 |
| Organon | 4 | $57 |
| Biofrontera Inc. | 2 | $44 |
| Kyowa Kirin, Inc. | 1 | $28 |
| Boehringer Ingelheim | 1 | $26 |
| Sandoz | 1 | $21 |
| Botanix SB Inc | 1 | $20 |
| Fresenius Kabi USA, LLC | 1 | $20 |
| Journey Medical Corporation | 1 | $16 |
How this compares
$4,351 in reported general payments places this provider in the 60th percentile of 475 dermatology providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 34 | $151,235 |
| Humira(Cf) PenAdalimumab | 12 | $119,257 |
| Cosentyx Sensoready (2 Pens)Secukinumab | 13 | $91,020 |
| Dupixent SyringeDupilumab | 14 | $51,458 |
| Clobetasol Propionate | 115 | $6,698 |
| Clindamycin Phosphate | 39 | $1,662 |
| Ketoconazole | 74 | $909 |
| Triamcinolone Acetonide | 66 | $744 |
| Fluocinonide | 11 | $721 |
| Tacrolimus | 11 | $618 |
| Doxycycline Monohydrate | 13 | $489 |
| Metronidazole | 12 | $475 |
| MethotrexateMethotrexate Sodium | 24 | $400 |
| Doxycycline Hyclate | 25 | $344 |
| Hydrocortisone | 43 | $320 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Chapel Hill
- Christopher SayedChapel Hill$3.3M
- Aida Lugo-SomolinosChapel Hill$2.2M
- Sue Ellen CoxChapel Hill$1.8M
- Donna CultonChapel Hill$424K
- Chris AdigunChapel Hill$71K
- Priyanka VedakChapel Hill$25K
- Rosalyn GeorgeWilmington$6.5M
- Steven FeldmanWinston Salem$4.3M
- Adnan NasirRaleigh$4.1M
- Zoe DraelosHigh Point$3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.